Clinicopathologic Significance of Putative Stem Cell Marker, CD44 and CD133, in Human Gastric Carcinoma

Tumor-Initiating Label-Retaining Cancer Cells in Human Gastrointestinal Cancers Undergo Asymmetric Cell Division

(2012) Hong-Wu Xin et al.   STEM CELLS

CD44 Variant Regulates Redox Status in Cancer Cells by Stabilizing the xCT Subunit of System xc− and Thereby Promotes Tumor Growth

(2011) Takatsugu Ishimoto et al.   CANCER CELL

CD133+ liver cancer stem cells modulate radioresistance in human hepatocellular carcinoma

(2011) Lian Shu Piao et al.   CANCER LETTERS

CD133 is a marker of gland-forming cells in gastric tumors and Sox17 is involved in its regulation

(2011) Hiroshi Fukamachi et al.   CANCER SCIENCE

Isolation of Live Label-Retaining Cells and Cells Undergoing Asymmetric Cell Division via Nonrandom Chromosomal Cosegregation from Human Cancers

(2011) Danielle Hari et al.   STEM CELLS AND DEVELOPMENT

Aberrant expression of CD133 protein correlates with Ki-67 expression and is a prognostic marker in gastric adenocarcinoma

(2010) Po Zhao et al.   BMC CANCER

Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM and ALDH1 in colorectal cancer

(2010) A Lugli et al.   BRITISH JOURNAL OF CANCER

Global Patterns of Cancer Incidence and Mortality Rates and Trends

(2010) A. Jemal et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Decreased expression of PinX1 protein is correlated with tumor development and is a new independent poor prognostic factor in ovarian carcinoma

(2010) Mu-Yan Cai et al.   CANCER SCIENCE

Expressions and clinical significances of CD133 protein and CD133 mRNA in primary lesion of gastric adenocacinoma

(2010) Ji-wei Yu et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

CD133 expression in different stages of gastric adenocarcinoma

(2009) M Boegl et al.   BRITISH JOURNAL OF CANCER

Identification of Gastric Cancer Stem Cells Using the Cell Surface Marker CD44

(2009) Shigeo Takaishi et al.   STEM CELLS

CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers

(2008) L M Smith et al.   BRITISH JOURNAL OF CANCER

The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells

(2008) Sendurai A. Mani et al.   CELL